USD $330.00
IndiaNelova, with the active ingredient Nilotinib, is an advanced medication primarily used for the treatment of certain types of leukemia, particularly chronic myeloid leukemia (CML). This targeted therapy works by inhibiting specific proteins that contribute to the growth and spread of cancer cells.
Nilotinib functions as a tyrosine kinase inhibitor, specifically targeting the BCR-ABL fusion protein that is responsible for the uncontrolled proliferation of cancer cells in CML. By blocking this protein, Nelova helps to slow down or stop the progression of the disease.
Nelova is prescribed for adult patients diagnosed with chronic myeloid leukemia in the chronic phase or accelerated phase. It is essential for patients to discuss their medical history and any other medications they are taking with their healthcare provider before starting treatment.
Common side effects of Nelova may include nausea, headache, fatigue, and skin rash. More severe side effects can occur, such as liver problems, heart rhythm issues, and low blood cell counts. Patients should report any unusual symptoms to their healthcare provider immediately.
Nelova is typically taken orally, with or without food. It is crucial to follow the dosage prescribed by a healthcare professional and to take the medication at the same time each day to maintain consistent levels in the body.
Patients should avoid grapefruit and grapefruit juice while taking Nelova, as they can interfere with the medication's effectiveness. Regular monitoring of blood counts and liver function is essential during treatment.
Nelova (Nilotinib) represents a significant advancement in the treatment of chronic myeloid leukemia, offering patients a targeted approach to managing their condition. Always consult with a healthcare provider for personalized medical advice and treatment options.
